Examination of utility of bisphosphonate to osteoporosis by ovarian insufficiency after gynecologic cancer treatment
Not Applicable
- Conditions
- Osteoporosis after gynecologic cancer treatment
- Registration Number
- JPRN-UMIN000005665
- Lead Sponsor
- Gifu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Cases that are impossible to measure by DXA and judge bone fractures 2)Cases that receive administering bisphosphonates before start of this examination 3)Cases that have advanced renal damage 4)Cases that have upper digestive canal disturbance 5)Cases that receive resection of stomach and wide gut 6)Cases that have previous history of hypersensitivity for elements of this medicine and other bisphosphonates 7)Cases with hypocalcemia 8)Cases that cannot keep upright or sitting positioning for 30 minutes or more when taking it
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The changes of bone mineral density and biochemical markers of turnover after two years from administering beginning
- Secondary Outcome Measures
Name Time Method